Disclosure Panels Details Page
Ovarian Cancer Panel - Disclosures as of 11/13/2015
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Ronald Alvarez MD | None | Celsion-Egen Genentech, Inc. |
None | None | ✔ |
| Deborah Armstrong MD | Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP clovis |
None | None | None | ✔ |
| Jamie Bakkum-Gamez MD | None | None | None | None | - |
| Kian Behbakht MD | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | ✔ |
| Jennifer Burns BS | None | None | None | None | ✔ |
| Lee-May Chen MD | None | Genentech, Inc. | Genentech, Inc. | None | ✔ |
| Larry Copeland MD | GOG Foundation NRG Oncology Tesaro |
Advaxis Bayer HealthCare Cerulean Endocyte Helomics Johnson & Johnson |
None | None | ✔ |
| Marta Ann Crispens MD | AstraZeneca Pharmaceuticals LP Janssen Pharmaceutica Products, LP |
Helomics | None | None | ✔ |
| Oliver Dorigo MD, PhD | None | None | None | None | - |
| Mary Dwyer MS | None | None | None | None | - |
| Fayna Ferkle PharmD | None | None | None | None | ✔ |
| Lauren Gallagher | None | None | None | None | ✔ |
| David Gershenson MD | National Cancer Institute | None | None | Biogen Idec|Celgene Corporation|Elsevier|Johnson & Johnson|National Cancer Institute|Proctor and Gamble|UpToDate | ✔ |
| Heidi Gray MD | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Ardeshir Hakam MD | None | None | None | None | ✔ |
| Laura Havrilesky MD | None | None | None | None | - |
| Miranda Hughes PhD | None | None | None | None | ✔ |
| Carolyn Johnston MD | None | None | external advisor/mentor for gyn oncology fellowship in Ethiopia Michigan Cancer Consortium MPRO |
american cancer society|american cancer society document reviewer|michigan cancer consortium|see 3a | ✔ |
| Shashikant Lele MD | None | None | None | None | ✔ |
| Lacey Marlow | None | None | None | None | ✔ |
| Lainie Martin MD | Novartis Pharmaceuticals Corporation Synta Pharmaceuticals Corp. |
None | None | None | ✔ |
| Ursula Matulonis MD | None | AstraZeneca Pharmaceuticals LP Genentech, Inc. Immunogen Merck & Co., Inc. Pfizer Inc. Tesaro |
None | None | ✔ |
| Joan McClure MS | None | None | None | None | ✔ |
| Robert Morgan MD, FACP | None | None | None | None | ✔ |
| David O'Malley MD | Ajinomoto Inc. Amgen Inc. Array Biopharma AstraZeneca Pharmaceuticals LP Clovis EMD Serono Genentech, Inc. Immunogen Janssen Pharmaceutica Products, LP Regeneron VEntiRx |
AstraZeneca Pharmaceuticals LP Eisai Inc. Genentech, Inc. |
None | None | ✔ |
| Richard Penson MD, MRCP | Amgen Inc. AstraZeneca Pharmaceuticals LP Eisai Inc. Endocyte Inc. Genentech, Inc. ImClone Systems Incorporated Vascular Biogenics Ltd |
AstraZeneca Pharmaceuticals LP Genentech, Inc. Vascular Biogenics, Ltd |
None | None | ✔ |
| Mario Pineda MD, PhD | NA | NA | NA | NA | - |
| Steven Plaxe MD, FACOG, FACS | Amgen Inc. AstraZeneca Pharmaceuticals LP azaya bind endocyte Janssen Pharmaceutica Products, LP Millennium Pharmaceuticals, Inc. navidia Novartis Pharmaceuticals Corporation Pfizer Inc. pharma mar Tesaro |
Ambrx Insys |
insys | Abbott Laboratories|AbbVie, Inc.|Bristol Myers Squibb|Pfizer Inc. | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Matthew Powell MD | Bristol Myers Squibb Eisai Inc. |
AnorMED Inc. Genentech, Inc. |
Genentech, Inc. | None | ✔ |
| Elena Ratner MD, MBA | None | None | None | None | - |
| Steven Remmenga MD | None | None | None | None | ✔ |
| Peter Rose MD | None | None | None | None | ✔ |
| Paul Sabbatini MD | Bristol Myers Squibb | None | None | None | - |
| Joseph Santoso MD | None | None | None | None | - |
| Theresa Werner MD | None | None | None | None | - |